Intravenous Solutions Market, By Solution (Saline (Normal Saline (0.9% NaCl) and Hypertonic Saline), Dextran, Lactated Ringer’s, Amino Acid, Vitamins & Minerals, Heparin and Trace Elements, and Mixed Solutions), By Bag Type (Large Volume Bags (greater tha

Intravenous Solutions Market, By Solution (Saline (Normal Saline (0.9% NaCl) and Hypertonic Saline), Dextran, Lactated Ringer’s, Amino Acid, Vitamins & Minerals, Heparin and Trace Elements, and Mixed Solutions), By Bag Type (Large Volume Bags (greater than 250ml) and Small Volume Bags (less than 250ml)), By Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, and Irrigation IV Solution), By End-user (Hospitals, Clinics, Ambulatory Surgery Centers, and Home Care Settings), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, nonpyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others.
Market Dynamics
Increasing prevalence of diarrhoea is expected to boost the global intravenous solution market growth over the forecast period. For instance, according to the World Health Organization (WHO), in May 2017, there were around 1.7 billion annual cases of childhood diarrheal disease across the globe.
Moreover, according to an article published in the Lancet Infectious Diseases, September 2021, diarrhoea was the third leading cause of disability-adjusted life year (DALYs) in 2016, which accounted for 74.4 million DALYs, globally. According to the same source, diarrhoea was the eighth leading cause of death, which accounted for 1,655,944 deaths in 2016.
Increasing cost of vitamin C intravenous therapy is expected to hinder the global intravenous solution market growth. For instance, in 2017, the China government took regulatory action of lowering vitamin C production owing to environmental concerns. This led to increase in prices of vitamin C by around 300% over the year. Furthermore, China produces 95% of the world’s vitamin C, which is used in food products, dietary supplements, and pharmaceuticals. The price of vitamin C was US$ 3.50 per kg in October 2016, which increased to US$ 12 per kg by September 2017, owing to environmental issues, which decreased China’s 30% of the vitamin C production.
Key features of the study:
This report provides in-depth analysis of the global intravenous solution market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global intravenous solution market based on the following parameters–company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Baxter International Inc. ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global intravenous solution market report caters to various stakeholders in this industry, such as investors, product manufacturers, distributors, and suppliers for global intravenous solution market , research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:
Global Intravenous Solution Market , By Solution Type:
Saline
Normal Saline (0.9% NaCl)
Hypertonic Saline
Dextran
Lactated Ringer’s
Amino Acid
Vitamins & Minerals
Heparin and Trace Elements
Mixed Solutions
Global Intravenous Solution Market , By Bag Type:
Large Volume Bags (greater than 250ml)
Small Volume Bags (less than 250ml)
Global Intravenous Solution Market , By Application:
Basic IV Solution
Nutritional IV Solution
Blood IV Solution
Drug IV Solution
Irrigation IV Solution
Global Intravenous Solution Market , By End-user:
Hospitals
Clinics
Ambulatory Surgery Centers
Home Care Settings
Global Intravenous Solution Market , By Region:
North America
By Country:
U.S.
Canada
By Solution Type :
Saline
Normal Saline (0.9% NaCl)
Hypertonic Saline
Dextran
Lactated Ringer’s
Amino Acid
Vitamins & Minerals
Heparin and Trace Elements
Mixed Solutions
By Bag Type:
Large Volume Bags (greater than 250ml)
Small Volume Bags (less than 250ml)
By Application:
Basic IV Solution
Nutritional IV Solution
Blood IV Solution
Drug IV Solution
Irrigation IV Solution
By End-user:
Hospitals
Clinics
Ambulatory Surgery Centers
Home Care Settings
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Solution Type :
Saline
Normal Saline (0.9% NaCl)
Hypertonic Saline
Dextran
Lactated Ringer’s
Amino Acid
Vitamins & Minerals
Heparin and Trace Elements
Mixed Solutions
By Bag Type:
Large Volume Bags (greater than 250ml)
Small Volume Bags (less than 250ml)
By Application:
Basic IV Solution
Nutritional IV Solution
Blood IV Solution
Drug IV Solution
Irrigation IV Solution
By End-user:
Hospitals
Clinics
Ambulatory Surgery Centers
Home Care Settings
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Solution Type :
Saline
Normal Saline (0.9% NaCl)
Hypertonic Saline
Dextran
Lactated Ringer’s
Amino Acid
Vitamins & Minerals
Heparin and Trace Elements
Mixed Solutions
By Bag Type:
Large Volume Bags (greater than 250ml)
Small Volume Bags (less than 250ml)
By Application:
Basic IV Solution
Nutritional IV Solution
Blood IV Solution
Drug IV Solution
Irrigation IV Solution
By End-user:
Hospitals
Clinics
Ambulatory Surgery Centers
Home Care Settings
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Solution Type :
Saline
Normal Saline (0.9% NaCl)
Hypertonic Saline
Dextran
Lactated Ringer’s
Amino Acid
Vitamins & Minerals
Heparin and Trace Elements
Mixed Solutions
By Bag Type:
Large Volume Bags (greater than 250ml)
Small Volume Bags (less than 250ml)
By Application:
Basic IV Solution
Nutritional IV Solution
Blood IV Solution
Drug IV Solution
Irrigation IV Solution
By End-user:
Hospitals
Clinics
Ambulatory Surgery Centers
Home Care Settings
Middle East
By Country/Region:
GCC
Israel
Rest of Middle East
By Solution Type :
Saline
Normal Saline (0.9% NaCl)
Hypertonic Saline
Dextran
Lactated Ringer’s
Amino Acid
Vitamins & Minerals
Heparin and Trace Elements
Mixed Solutions
By Bag Type:
Large Volume Bags (greater than 250ml)
Small Volume Bags (less than 250ml)
By Application:
Basic IV Solution
Nutritional IV Solution
Blood IV Solution
Drug IV Solution
Irrigation IV Solution
By End-user:
Hospitals
Clinics
Ambulatory Surgery Centers
Home Care Settings
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Solution Type :
Saline
Normal Saline (0.9% NaCl)
Hypertonic Saline
Dextran
Lactated Ringer’s
Amino Acid
Vitamins & Minerals
Heparin and Trace Elements
Mixed Solutions
By Bag Type:
Large Volume Bags (greater than 250ml)
Small Volume Bags (less than 250ml)
By Application:
Basic IV Solution
Nutritional IV Solution
Blood IV Solution
Drug IV Solution
Irrigation IV Solution
By End-user:
Hospitals
Clinics
Ambulatory Surgery Centers
Home Care Settings
Company Profiles
Baxter International Inc.*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
ICU Medical, Inc.
B. Braun Melsungen Ag
Grifols, S.A.
Fresenius Kabi USA, LLC
Vifor Pharma Management Ltd.
JW Life Science
Amanta Healthcare
Axa Parenterals Ltd.
Salius Pharma Private Limited.

“*” marked represents similar segmentation in other categories in the respective section.